MX9700342A - Derivados acilicos de azolonas anti-helicobacter. - Google Patents

Derivados acilicos de azolonas anti-helicobacter.

Info

Publication number
MX9700342A
MX9700342A MX9700342A MX9700342A MX9700342A MX 9700342 A MX9700342 A MX 9700342A MX 9700342 A MX9700342 A MX 9700342A MX 9700342 A MX9700342 A MX 9700342A MX 9700342 A MX9700342 A MX 9700342A
Authority
MX
Mexico
Prior art keywords
4alkyl
halo
hydrogen
compounds
optionally substituted
Prior art date
Application number
MX9700342A
Other languages
English (en)
Inventor
Jan Heeres
Raymond Antoine Stokbroekx
Joseph Hector Mostmans
Louis Josef Elizabeth Va Veken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9700342A publication Critical patent/MX9700342A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polymerization Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La invencion se refiere a los compuestos que tienen la formula (I), las sales de adicion farmacéuticamente aceptables y las formas estereoquímicamente isoméricas de los mismos, en donde Y es CH o N; R1, R2 y R3 son independientemente cada uno hidrogeno o alquilo de C1-4; R4 y R5 son cada uno independientemente hidrogeno, halogeno, alquilo de C1-4, alquiloxilo de C1-4, hidroxilo, trifluorometilo, trifluorometiloxi o difluorometiloxi, R6 es hidrogeno; o R6 es fenilo substituido opcionalmente con halogeno; piridinilo; furanilo; tienilo, 3-cloro-benzo[b]tien-2-ilo; trifluorometilo; alquiloxicarbonilo de C1-4; dihalogenofenilciclopropanilo; cicloalquilo de C3-6, adamantilo; alquenilo de C2-6 substituido opcionalmente con halogenofenilo; o alquilo de C1-4 substituido opcionalmente con halogeno, fenilo, halogenofenilo, dihalogenofenilo, feniloxi, piperidinilo, pirrolidinilo, piperazinilo, alquilpiperazinilo de C1-4, alquilcarbonilpiperazinilo de C1-4, alquiloxicarbonilpiperazinilo de C1-4, ftalimino, amino, mono- o di-alquilamino de C1-20 o cicloalquilamino de C3-6; es C=O o CHOH, y (1) es un radical de formula (a-1), (a-2), (a-3), (a-4, (a-5), (a-6) o (a-7); composiciones que comprenden dichos compuestos, procedimiento para la preparacion de los mismos y el uso de estos compuestos como una medicina.
MX9700342A 1994-07-12 1995-07-05 Derivados acilicos de azolonas anti-helicobacter. MX9700342A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202019 1994-07-12
PCT/EP1995/002618 WO1996001822A1 (en) 1994-07-12 1995-07-05 Anti-helicobacter acyl derivatives of azolones

Publications (1)

Publication Number Publication Date
MX9700342A true MX9700342A (es) 1997-05-31

Family

ID=8217032

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700342A MX9700342A (es) 1994-07-12 1995-07-05 Derivados acilicos de azolonas anti-helicobacter.

Country Status (21)

Country Link
US (1) US5637592A (es)
EP (1) EP0770074A1 (es)
JP (1) JPH10502385A (es)
CN (1) CN1071331C (es)
AU (1) AU685310B2 (es)
BR (1) BR9508377A (es)
CA (1) CA2193490A1 (es)
CZ (1) CZ2897A3 (es)
FI (1) FI970112A (es)
HU (1) HUT76638A (es)
IL (1) IL114536A (es)
MX (1) MX9700342A (es)
MY (1) MY131727A (es)
NO (1) NO310290B1 (es)
NZ (1) NZ290118A (es)
PH (1) PH31455A (es)
PL (1) PL318140A1 (es)
RU (1) RU2152392C1 (es)
SK (1) SK4397A3 (es)
WO (1) WO1996001822A1 (es)
ZA (1) ZA955759B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
JP4960085B2 (ja) * 2003-03-19 2012-06-27 エクセリクシス， インク． Ｔｉｅ−２モジュレータと使用方法
ZA200702645B (en) * 2004-09-17 2008-08-27 Vertex Pharma Diaminotriazole compounds useful as protein kinase inhibitors
AU2005286728A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
US7777036B2 (en) * 2004-09-20 2010-08-17 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
CA2580856A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
AU2005286790A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD)
AU2005286793A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
EP1804799B1 (en) * 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
MX2007003325A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores estearoil-coa-desaturasa.
AR051095A1 (es) * 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso comoinhibidores de la estearoil-coa desaturasa
AU2005286731A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
US8981094B2 (en) 2007-06-08 2015-03-17 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
US8835437B2 (en) * 2007-06-08 2014-09-16 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
EP2152269B1 (en) 2007-06-08 2014-04-23 Janssen Pharmaceutica, N.V. Piperidine/piperazine derivatives
EP2801565B1 (en) * 2013-05-06 2015-07-22 King Saud University Compounds for use as anti-ulcer agent and/or anti-Helicobacter pylori agent and pharmaceutical compositions thereof
CA2982660C (en) 2014-11-21 2023-01-24 F2G Limited 2-(1,5-dimethyl-3-phenyl-1h-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazine-1-yl)phenyl)-2-oxoacetamide and derivatives thereof for use as antifungal agents
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
TW218017B (es) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
TW279864B (es) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones

Also Published As

Publication number Publication date
NZ290118A (en) 1997-11-24
WO1996001822A1 (en) 1996-01-25
BR9508377A (pt) 1997-10-28
FI970112A0 (fi) 1997-01-10
IL114536A (en) 1999-04-11
HUT76638A (en) 1997-10-28
CA2193490A1 (en) 1996-01-25
RU2152392C1 (ru) 2000-07-10
CZ2897A3 (en) 1997-10-15
AU3075795A (en) 1996-02-09
NO310290B1 (no) 2001-06-18
NO970088L (no) 1997-03-10
PL318140A1 (en) 1997-05-12
SK4397A3 (en) 1997-11-05
US5637592A (en) 1997-06-10
JPH10502385A (ja) 1998-03-03
AU685310B2 (en) 1998-01-15
FI970112A (fi) 1997-01-10
CN1152311A (zh) 1997-06-18
HU9700076D0 (en) 1997-02-28
PH31455A (en) 1998-11-03
EP0770074A1 (en) 1997-05-02
IL114536A0 (en) 1995-11-27
NO970088D0 (no) 1997-01-09
ZA955759B (en) 1997-01-13
MY131727A (en) 2007-08-30
CN1071331C (zh) 2001-09-19

Similar Documents

Publication Publication Date Title
MX9700342A (es) Derivados acilicos de azolonas anti-helicobacter.
MX9700340A (es) Agentes anti-helicobacter derivados sulfonamida de azolonas.
MX9700339A (es) Derivados de azolona anti-helcobacter que contienen urea y tiourea.
TR200102042T2 (tr) Spiro fropiridinlerin, tedavide faydalı yeni aralkil aminleri.
TWI256389B (en) Novel hPPAR delta agonists and pharmaceutical compositions comprising the same
CO5271691A1 (es) Nuevos compuestos
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
ZA954548B (en) Monoamine diamide thiol-containing metal chelating agents
GB9024730D0 (en) Diazine derivatives
AP9701041A0 (en) Pyridylpyrrole compounds.
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
DK57492A (da) Farmaceutiske praeparater af n-phenylbenzamidderivater
FR2678929B1 (es)
BR9502085A (pt) Derivado de 11,21-bis-fenil-19-norpregnano,processo de preparação do mesmo e composição farmaceutica
CA2136553A1 (en) 7-(2-aminoethyl)-Benzothiazolones
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
MY132057A (en) Quinoxalinones, a process for their preparation and their use
ES8507502A1 (es) Un procedimiento para preparar antra (1, 9-cd) pirazol-6(2h)-onas
GB8829593D0 (en) Novel compounds
BG105008A (en) Hygromycin a derivatives
BR9507289A (pt) Derivados de éster e carbamato de azolonas com atividade anti-heli-cobacteriana
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate